ICON plc: ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model

Partnership will integrate ICON's clinical trial technology with Advarra's purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership ...
Fierce Biotech

Icon, Advarra partnership aims to optimize trials, expand access

Clinical research organization Icon has entered into a partnership with research technology company Advarra to launch a ...
Morningstar

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup.
Seeking Alpha

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of ...